Compare RKLB & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RKLB | ALC |
|---|---|---|
| Founded | 2006 | 1945 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Aerospace | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.7B | 39.0B |
| IPO Year | N/A | N/A |
| Metric | RKLB | ALC |
|---|---|---|
| Price | $90.71 | $79.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 12 |
| Target Price | $51.42 | ★ $88.29 |
| AVG Volume (30 Days) | ★ 29.0M | 1.1M |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 0.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.10 |
| Revenue | $554,535,000.00 | ★ $10,185,000,000.00 |
| Revenue This Year | $40.29 | $5.76 |
| Revenue Next Year | $46.77 | $7.24 |
| P/E Ratio | ★ N/A | $37.43 |
| Revenue Growth | ★ 52.42 | 4.34 |
| 52 Week Low | $14.71 | $71.55 |
| 52 Week High | $92.19 | $99.20 |
| Indicator | RKLB | ALC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 49.83 |
| Support Level | N/A | $77.89 |
| Resistance Level | N/A | $81.65 |
| Average True Range (ATR) | 0.00 | 1.51 |
| MACD | 0.00 | -0.15 |
| Stochastic Oscillator | 0.00 | 49.13 |
Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, and rest of the world and earns key revenue from the United States.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.